Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Damien Bates, MD, PhD, FRACS (Plast.)
Organogenesis Inc.
Study Director - Elizabeth Alvarez- Connelly, MD
University of Miami
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University School of Medicine
Stanford, California, United States
- University of Miami - Miller School of Medicine
Miami, Florida, United States
- Columbia University Medical Center
New York, New York, United States
- Children'S Hospital of Cincinnati
Cincinnati, Ohio, United States
- University of Texas
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 31 Dec 2008
- Completion
- 31 Dec 2008
- Last update posted
- 29 Jun 2010
- Registered enrollment
- 1
- Registry id
- NCT00587223
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.